Bicycle Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 25 shareholders own 87.07% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.77%	Deep Track Capital, LP	2,900,000	$81.2m	0%	2.93%
6.74%	Logos Global Management, L.P.	2,000,000	$56.0m	17.65%	6.62%
5.9%	Cambridge Innovation Capital Jersey Limited	1,751,437	$49.0m	0%	no data
5.66%	Janus Henderson Group plc	1,680,849	$47.1m	22.29%	0.02%
5.26%	SV Health Investors, LLC	1,562,451	$43.7m	0%	10.29%
5.15%	SR One Capital Management, LP	1,529,561	$42.8m	0%	13.48%
4.36%	Samlyn Capital, LLC	1,294,085	$36.2m	24.4%	0.58%
4.3%	RTW Investments, LP	1,276,276	$35.7m	0%	0.67%
4.23%	Point72 Asset Management, L.P.	1,255,418	$35.2m	-13.12%	0.08%
4.15%	Candriam Luxembourg S.A.	1,232,254	$34.5m	47.63%	0.1%
3.9%	Paradigm Biocapital Advisors LP	1,158,686	$32.4m	10.51%	4.22%
3.51%	Tybourne Capital Management (HK) Ltd.	1,041,331	$29.2m	-9.77%	2.33%
2.9%	Morgan Stanley, Investment Banking and Brokerage Investments	859,844	$24.1m	4.71%	no data
2.88%	Eventide Asset Management, LLC	853,800	$23.9m	0%	0.41%
2.84%	Baker Bros. Advisors LP	843,814	$23.6m	0%	0.12%
2.37%	First Light Asset Management, LLC	704,721	$19.7m	0.06%	1.87%
2.3%	Sio Capital Management, LLC	683,425	$19.1m	-0.81%	6.41%
2.27%	Novartis Venture Funds	673,360	$18.9m	0%	65.26%
2.24%	FMR LLC	664,806	$18.6m	-6.11%	no data
1.41%	T. Rowe Price Group, Inc.	417,340	$11.7m	-0.93%	no data
1.38%	AXA Investment Managers S.A.	410,640	$11.5m	-11.31%	0.02%
1.17%	Verition Fund Management LLC	348,513	$9.8m	-12.66%	0.15%
0.88%	Two Sigma Advisers, LP	262,700	$7.4m	-36.73%	0.02%
0.78%	Kevin Lee	231,585	$6.5m	2.89%	no data
0.72%	Pura Vida Investments, LLC	213,121	$6.0m	16.38%	0.81%